PAULO A MELO

Prof. PAULO A MELO

FARMACOLOGIA - UFRJ Universidade Federal do Rio de Janeiro, RJ, BRAZIL

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2014 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FFFabrício F.A. Fernandes
Fabrício F.A. Fernandes
MTMarcelo A. Tomaz
Marcelo A. Tomaz
CECamila Z. El-Kik
Camila Z. El-Kik
Marcos Monteiro-MachadoMarcos Monteiro-Machado
Marcos Monteiro-Machado
MSMarcelo A. Strauch
Marcelo A. Strauch
PMPAULO A MELO
PAULO A MELO

1 May 2015 in Toxicon
Verified
Journal Article
Closed access
Marcos Monteiro-MachadoMarcos Monteiro-Machado
Marcos Monteiro-Machado
MTMarcelo A. Tomaz
Marcelo A. Tomaz
RFRoberto Fonseca
Roberto Fonseca
MSMarcelo A. Strauch
Marcelo A. Strauch
BCBruno L. Cons
Bruno L. Cons
PMPAULO A MELO
PAULO A MELO

28 January 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MSMarcelo Abrahão Strauch
Marcelo Abrahão Strauch
MTMarcelo Amorim Tomaz
Marcelo Amorim Tomaz
Marcos Monteiro-MachadoMarcos Monteiro-Machado
Marcos Monteiro-Machado
BCBruno Lemos Cons
Bruno Lemos Cons
FPFernando Chagas Patrão-Neto
Fernando Chagas Patrão-Neto
PMPAULO A MELO
PAULO A MELO
It is known that local tissue injuries incurred by snakebites are quickly instilled causing extensive, irreversible, tissue destruction that may include loss of limb function or even amputation. Such injuries are not completely neutralized by the available antivenins, which in general are focused on halting systemic effects. Therefore it is prudent to investigate the potential antiophidic effects of natural and synthetic compounds, perhaps combining them with serum therapy, to potentially attenuate or eliminate the adverse local and systemic effects of snake venom. This study assessed a group of quinones that are widely distributed in nature and constitute an important class of natural products that exhibit a range of biological activities. Of these quinones, lapachol is one of the most important compounds, having been first isolated in 1882 from the bark of Tabebuia avellanedae. It was investigated the ability of lapachol and some new potential active analogues based on the 2-hydroxi-naphthoquinone scaffold to antagonize important activities of Bothrops venoms (Bothrops atrox and Bothrops jararaca) under different experimental protocols in vitro and in vivo. The bioassays used to test the compounds were: procoagulant, phospholipase A2, collagenase and proteolytic activities in vitro, venom-induced hemorrhage, edematogenic, and myotoxic effects in mice. Proteolytic and collagenase activities of Bothrops atrox venom were shown to be inhibited by lapachol and its analogues 3a, 3b, 3c, 3e. The inhibition of these enzymatic activities might help to explain the effects of the analogue 3a in vivo, which decreased skin hemorrhage induced by Bothrops venom. Lapachol and the synthetic analogues 3a and 3b did not inhibit the myotoxic activity induced by Bothrops atrox venom. The negative protective effect of these compounds against the myotoxicity can be partially explained by their lack of ability to effectively inhibit phospholipase A2 venom activity. Bothrops atrox venom also induced edema, which was significantly reduced by the analogue 3a. This research using a natural quinone and some related synthetic quinone compounds has shown that they exhibit antivenom activity; especially the compound 3a. The data from 3a showed a decrease in inflammatory venom effects, presumably those that are metalloproteinase-derived. Its ability to counteract such snake venom activities contributes to the search for improving the management of venomous snakebites.

1 June 2012 in Brazilian Journal of Medical and Biological Research
Verified
Journal Article
Open access
PDF file
JSJ. Saturnino-Oliveira
J. Saturnino-Oliveira
MTM.A. Tomaz
M.A. Tomaz
TFT.F. Fonseca
T.F. Fonseca
GGG.A. Gaban
G.A. Gaban
Marcos Monteiro-MachadoMarcos Monteiro-Machado
Marcos Monteiro-Machado
PMPAULO A MELO
PAULO A MELO
We studied the effect of pulsed ultrasound therapy (UST) and antibothropic polyvalent antivenom (PAV) on the regeneration of mouse extensor digitorum longus muscle following damage by Bothrops jararacussu venom. Animals (Swiss male and female mice weighing 25.0 ± 5.0 g; 5 animals per group) received a perimuscular injection of venom (1 mg/kg) and treatment with UST was started 1 h later (1 min/day, 3 MHz, 0.3 W/cm(2), pulsed mode). Three and 28 days after injection, muscles were dissected and processed for light microscopy. The venom caused complete degeneration of muscle fibers. UST alone and combined with PAV (1.0 mL/kg) partially protected these fibers, whereas muscles receiving no treatment showed disorganized fascicules and fibers with reduced diameter. Treatment with UST and PAV decreased the effects of the venom on creatine kinase content and motor activity (approximately 75 and 48%, respectively). Sonication of the venom solution immediately before application decreased the in vivo and ex vivo myotoxic activities (approximately 60 and 50%, respectively). The present data show that UST counteracts some effects of B. jararacussu venom, causing structural and functional improvement of the regenerated muscle after venom injury.

5 January 2021 in Toxins
Verified
Journal Article
Open access
PDF file
JCJhonatha Cruz
Jhonatha Cruz
MSMarcelo Abrahão Strauch
Marcelo Abrahão Strauch
Marcos Monteiro-MachadoMarcos Monteiro-Machado
Marcos Monteiro-Machado
MTMatheus Silva Tavares-Henriques
Matheus Silva Tavares-Henriques
JMJoão Alfredo Moraes
João Alfredo Moraes
PMPAULO A MELO
PAULO A MELO
Massive, Africanized honeybee attacks have increased in Brazil over the years. Humans and animals present local and systemic effects after envenomation, and there is no specific treatment for this potentially lethal event. This study evaluated the ability of a new Apilic antivenom, which is composed of F(ab’)2 fraction of specific immunoglobulins in heterologous and hyperimmune equine serum, to neutralize A. mellifera venom and melittin, in vitro and in vivo, in mice. Animal experiments were performed in according with local ethics committee license (UFRJ protocol no. DFBCICB072-04/16). Venom dose-dependent lethality was diminished with 0.25–0.5 μL of intravenous Apilic antivenom/μg honeybee venom. In vivo injection of 0.1–1 μg/g bee venom induced myotoxicity, hemoconcentration, paw edema, and increase of vascular permeability which were antagonized by Apilic antivenom. Cytotoxicity, assessed in renal LLC-PK1 cells and challenged with 10 μg/mL honeybee venom or melittin, was neutralized by preincubation with Apilic antivenom, as well the hemolytic activity. Apilic antivenom inhibited phospholipase and hyaluronidase enzymatic activities. In flow cytometry experiments, Apilic antivenom neutralized reduction of cell viability due to necrosis by honeybee venom or melittin. These results showed that this antivenom is effective inhibitor of honeybee venom actions. Thus, this next generation of Apilic antivenom emerges as a new promising immunobiological product for the treatment of massive, Africanized honeybee attacks.

10 April 2018 in Journal of Venomous Animals and Toxins including Tropical Diseases
Verified
Journal Article
Open access
PDF file
MSMarcelo Abrahão Strauch
Marcelo Abrahão Strauch
GSGuilherme Jones Souza
Guilherme Jones Souza
JPJordana Nahar Pereira
Jordana Nahar Pereira
TRTyelli dos Santos Ramos
Tyelli dos Santos Ramos
MCMarcelo Oliveira Cesar
Marcelo Oliveira Cesar
PMPAULO A MELO
PAULO A MELO
Bites provoked by the genus Micrurus represent less than 1% of snakebite cases notified in Brazil, a tiny fraction compared with other genus such as Bothrops and Crotalus, which together represent almost 80% of accidents. In addition to their less aggressive behavior, habits and morphology of coral snakes are determinant factors for such low incidence of accidents. Although Micrurus bites are rare, victims must be rescued and hospitalized in a short period of time, because this type of envenoming may evolve to a progressive muscle weakness and acute respiratory failure. We report an accident caused by Micrurus corallinus involving a 28-year-old Caucasian sailor man bitten on the hand. The accident occurred in a recreational camp because people believed the snake was not venomous. The victim presented neurological symptoms 2 h after the accident and was taken to the hospital, where he received antielapidic serum 10 h after the bite. After the antivenom treatment, the patient presented clinical evolution without complications and was discharged 4 days later. We reinforce that it is essential to have a health care structure suitable for the treatment of snakebite. Besides, the manipulation of these animals should only be carried out by a team of well-equipped and trained professionals, and even so with special attention.